MARC details
000 -LEADER |
fixed length control field |
04191naaaa2200937uu 4500 |
001 - CONTROL NUMBER |
control field |
https://directory.doabooks.org/handle/20.500.12854/68311 |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20220714180949.0 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
books978-3-0365-0187-1 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036501864 |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9783036501871 |
024 7# - OTHER STANDARD IDENTIFIER |
Standard number or code |
10.3390/books978-3-0365-0187-1 |
Terms of availability |
doi |
041 0# - LANGUAGE CODE |
Language code of text/sound track or separate title |
English |
042 ## - AUTHENTICATION CODE |
Authentication code |
dc |
072 #7 - SUBJECT CATEGORY CODE |
Subject category code |
M |
Source |
bicssc |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Viseras, César |
Relator code |
edt |
9 (RLIN) |
1597900 |
245 10 - TITLE STATEMENT |
Title |
Clay-Based Pharmaceutical Formulations and Drug Delivery Systems |
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
Place of publication, distribution, etc |
Basel, Switzerland |
Name of publisher, distributor, etc |
MDPI - Multidisciplinary Digital Publishing Institute |
Date of publication, distribution, etc |
2021 |
300 ## - PHYSICAL DESCRIPTION |
Extent |
1 electronic resource (202 p.) |
506 0# - RESTRICTIONS ON ACCESS NOTE |
Terms governing access |
Open Access |
Source of term |
star |
Standardized terminology for access restriction |
Unrestricted online access |
520 ## - SUMMARY, ETC. |
Summary, etc |
This book includes recent advances in the use of clays in the design of medicinal products and medicinal devices. The pharmaceutical applications of nanoclays are far ranging, because of their distinct advantages: they are versatile (possess a wide range of mechanical, chemical and physical properties) and available at reasonable costs. Some special clays (mainly kaolinite, halloysite, montmorillonite, saponite, hectorite, palygorskite and sepiolite), as well as semi-synthetic (organoclays) or synthetic (double layer hydroxides) derivatives, are very useful materials for modulating drug delivery. In the last decade, several actives have been loaded onto nanoclays and similar inorganic excipients to increase solubility, improve stability, reduce toxicity, and enhance bioavailability, with a consequent increase in therapeutic response. Polymer/clay nanocomposites with synergic properties have been developed, showing improved mechanical properties with respect to the pristine polymer matrices and allowing modified release of loaded actives. Moreover, nanoclays have very recently demonstrated positive effects on the proliferation and migration of fibroblasts. The development of clay-based medicinal products and medicinal devices requires experience in the fields of both clay structure and properties and pharmaceutical technology design. |
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE |
Terms governing use and reproduction |
Creative Commons |
-- |
https://creativecommons.org/licenses/by/4.0/ |
-- |
cc |
-- |
https://creativecommons.org/licenses/by/4.0/ |
546 ## - LANGUAGE NOTE |
Language note |
English |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine |
Source of heading or term |
bicssc |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydrochlorothiazide |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cyclodextrins |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
sepiolite |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
nanoclay |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
dissolution rate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
tablet |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
electrospinning |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chitosan |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
chondroitin sulfate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
scaffolds |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
montmorillonite |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
halloysite |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
fibroblasts proliferation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
immune response |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
glycosaminoglycans |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
antimicrobial properties |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
palygorskite |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
spring water |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydrogel |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
fibroblast |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
biocompatibility |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
wound healing |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
mesoporous clay |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Neusilin |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
aeroperl |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
liquisolid technique |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
glyburide |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
dissolution improvement |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydrotalcite |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
ketoprofen |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hybrid |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
photostability |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hydrogel film |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bioadhesion |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
heavy metal |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
hazardous element |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
element mobility |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
clay minerals |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
toxicity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
palygorksite |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
proliferation |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
Franz cell |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
bioactive elements |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
praziquantel |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
drug |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
organic solvents |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
in vitro dissolution tests |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
cytotoxicity |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
targeted drug delivery |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
halloysite nanotube |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
osteosarcoma |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
methotrexate |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
surface modification |
653 ## - INDEX TERM--UNCONTROLLED |
Uncontrolled term |
n/a |
700 1# - ADDED ENTRY--PERSONAL NAME |
Personal name |
Viseras, César |
Relator code |
oth |
9 (RLIN) |
1597900 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://mdpi.com/books/pdfview/book/3321">https://mdpi.com/books/pdfview/book/3321</a> |
-- |
0 |
Public note |
DOAB: download the publication |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Host name |
www.oapen.org |
Uniform Resource Identifier |
<a href="https://directory.doabooks.org/handle/20.500.12854/68311">https://directory.doabooks.org/handle/20.500.12854/68311</a> |
-- |
0 |
Public note |
DOAB: description of the publication |